356 related articles for article (PubMed ID: 24667640)
21. mTOR inhibitor INK128 attenuates systemic lupus erythematosus by regulating inflammation-induced CD11b
Shi G; Li D; Li X; Ren J; Xu J; Ding L; Dou H; Hou Y
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):1-13. PubMed ID: 30292636
[TBL] [Abstract][Full Text] [Related]
22. Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus.
Kato H; Perl A
J Immunol; 2014 May; 192(9):4134-44. PubMed ID: 24683191
[TBL] [Abstract][Full Text] [Related]
23. Calcium/Calmodulin-Dependent Kinase IV Facilitates the Recruitment of Interleukin-17-Producing Cells to Target Organs Through the CCR6/CCL20 Axis in Th17 Cell-Driven Inflammatory Diseases.
Koga T; Otomo K; Mizui M; Yoshida N; Umeda M; Ichinose K; Kawakami A; Tsokos GC
Arthritis Rheumatol; 2016 Aug; 68(8):1981-8. PubMed ID: 26945541
[TBL] [Abstract][Full Text] [Related]
24. B cells control lupus autoimmunity by inhibiting Th17 and promoting Th22 cells.
Yang J; Yang X; Wang L; Li M
Cell Death Dis; 2020 Mar; 11(3):164. PubMed ID: 32127533
[TBL] [Abstract][Full Text] [Related]
25. DDIT4 and Associated lncDDIT4 Modulate Th17 Differentiation through the DDIT4/TSC/mTOR Pathway.
Zhang F; Liu G; Li D; Wei C; Hao J
J Immunol; 2018 Mar; 200(5):1618-1626. PubMed ID: 29378913
[TBL] [Abstract][Full Text] [Related]
26. cAMP response element modulator α controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus.
Hedrich CM; Crispin JC; Rauen T; Ioannidis C; Apostolidis SA; Lo MS; Kyttaris VC; Tsokos GC
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16606-11. PubMed ID: 23019580
[TBL] [Abstract][Full Text] [Related]
27. Peripheral blood Th17/Treg imbalance in patients with low-active systemic lupus erythematosus.
Szmyrka-Kaczmarek M; Kosmaczewska A; Ciszak L; Szteblich A; Wiland P
Postepy Hig Med Dosw (Online); 2014; 68():893-8. PubMed ID: 24988609
[TBL] [Abstract][Full Text] [Related]
28. miR-146a modulates autoreactive Th17 cell differentiation and regulates organ-specific autoimmunity.
Li B; Wang X; Choi IY; Wang YC; Liu S; Pham AT; Moon H; Smith DJ; Rao DS; Boldin MP; Yang L
J Clin Invest; 2017 Oct; 127(10):3702-3716. PubMed ID: 28872459
[TBL] [Abstract][Full Text] [Related]
29. T Cell Metabolism: A New Perspective on Th17/Treg Cell Imbalance in Systemic Lupus Erythematosus.
Shan J; Jin H; Xu Y
Front Immunol; 2020; 11():1027. PubMed ID: 32528480
[TBL] [Abstract][Full Text] [Related]
30. KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3⁺ regulatory T cells in MRL/lpr mice.
Koga T; Mizui M; Yoshida N; Otomo K; Lieberman LA; Crispín JC; Tsokos GC
Autoimmunity; 2014 Nov; 47(7):445-50. PubMed ID: 24829059
[TBL] [Abstract][Full Text] [Related]
31. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
[TBL] [Abstract][Full Text] [Related]
32. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
33. The
Gorman JA; Hundhausen C; Kinsman M; Arkatkar T; Allenspach EJ; Clough C; West SE; Thomas K; Eken A; Khim S; Hale M; Oukka M; Jackson SW; Cerosaletti K; Buckner JH; Rawlings DJ
Front Immunol; 2019; 10():44. PubMed ID: 30740104
[TBL] [Abstract][Full Text] [Related]
34. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
35. B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway.
Herold M; Posevitz V; Chudyka D; Hucke S; Groß C; Kurth F; Leder C; Loser K; Kurts C; Knolle P; Klotz L; Wiendl H
J Immunol; 2015 Oct; 195(8):3584-95. PubMed ID: 26378076
[TBL] [Abstract][Full Text] [Related]
36. Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV.
Ichinose K; Juang YT; Crispín JC; Kis-Toth K; Tsokos GC
Arthritis Rheum; 2011 Feb; 63(2):523-9. PubMed ID: 20954187
[TBL] [Abstract][Full Text] [Related]
37. Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways.
Kim JS; Sklarz T; Banks LB; Gohil M; Waickman AT; Skuli N; Krock BL; Luo CT; Hu W; Pollizzi KN; Li MO; Rathmell JC; Birnbaum MJ; Powell JD; Jordan MS; Koretzky GA
Nat Immunol; 2013 Jun; 14(6):611-8. PubMed ID: 23644504
[TBL] [Abstract][Full Text] [Related]
38. In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics.
Mardani F; Mahmoudi M; Esmaeili SA; Khorasani S; Tabasi N; Rastin M
J Cell Physiol; 2018 Jan; 234(1):642-649. PubMed ID: 30078223
[TBL] [Abstract][Full Text] [Related]
39. MyD88 is essential to sustain mTOR activation necessary to promote T helper 17 cell proliferation by linking IL-1 and IL-23 signaling.
Chang J; Burkett PR; Borges CM; Kuchroo VK; Turka LA; Chang CH
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2270-5. PubMed ID: 23341605
[TBL] [Abstract][Full Text] [Related]
40. Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice.
Otomo K; Koga T; Mizui M; Yoshida N; Kriegel C; Bickerton S; Fahmy TM; Tsokos GC
J Immunol; 2015 Dec; 195(12):5533-7. PubMed ID: 26561550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
